Entourage
Investor ● Covered in 3 stories + Follow ✴ AI Graph Claim this firm
Entourage is tracked in TLDRocket’s investor dataset. Explore the recorded developments, relationships and supporting evidence below. Coverage reflects our monitored sources and may be incomplete.
Signals
2 stories (new)
Media momentum
As of 5 Nov 2026 · Visible stories in the last 30 days, compared with the 30 days before.
2 sources
Source diversity
As of 5 Nov 2026 · Distinct publications behind this entity's visible coverage.
4 investments
Investment activity
As of 5 Nov 2026 · Source-backed invests-in relationships tracked from this investor.
Jul 2026 → Oct 2026
Coverage span
As of 5 Nov 2026 · First to most recent month of TLDRocket coverage of this entity.
Management records
updated 5 Aug 2026Observed in public listings; this is not a verified current management roster.
- Pascal Brenneisen CEO
- Nils Sunder-Plassmann Head Of Pharma
- Dr. Jennifer Neff Vice President Medical Devices
- Dominique Hoff Managing Director Switzerland
Portfolio
Latest developments
2026
Funding: Aikido & Entourage Funding
Funding: Entourage & Aikido Funding
Funding: Conveo & Entourage Funding
Funding: Entourage & Lexroom Funding
Relationships
Investment & ownership
- Invests in Sightera Biosciences · 1 source
- Owns Entourage’s second fund · 1 source
- Owns Entourage’s first fund · 1 source
- Invests in Aikido · 1 source
- Invests in Conveo · 1 source
- Invests in Lexroom · 1 source